Riskpilot← Back to searchSign inGet full accessKHARMS 22 ApS
APSDissolvedCVR 31623162Bæverdalen 33Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 2008— employees
Revenue 2024
DKK -1K
EBITDA margin
100.0%
Equity ratio
100.0%
Financial strength
Net profit 2024
DKK -1K
-8% vs 2023
| Revenue | DKK -1K | — |
| EBITDA | DKK -1K | — |
| Net profit | DKK -1K | -8% |
| Total assets | DKK 141K | -1% |
| Equity | DKK 141K | -1% |
| Employees | — | — |
Legal name
KHARMS 22 ApS
CVR number
31623162
Legal form
Anpartsselskab
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
10. juli 2008
Share capital
DKK 125.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Address
Bæverdalen 33
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | -5 | 0 | 0 | 0 | 0 | — | — | -1 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -0 | -11 | 0 | 0 | 0 | -5 | 0 | 0 | 0 | 0 | 0 | 0 | -1 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -0 | -11 | 0 | 0 | 0 | -5 | 0 | 0 | 0 | 0 | 0 | 0 | -1 |
| Net financials | 61 | 30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -2 | -1 | 0 |
| Profit before tax | 25 | 19 | 0 | 0 | 0 | -5 | 0 | 0 | 0 | -1 | -2 | -1 | -1 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | 25 | 19 | 0 | 0 | 0 | -5 | 0 | 0 | 0 | -1 | -2 | -1 | -1 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 149 | 169 | 169 | 169 | 150 | 145 | 145 | 145 | 145 | 145 | 143 | 142 | 141 |
| Equity | 118 | 138 | 138 | 138 | 150 | 145 | 145 | 145 | 145 | 145 | 143 | 142 | 141 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 31 | 31 | 31 | 31 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total debt | 31 | 31 | 31 | 31 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITDA margin
-118800.0%
This company
15.8%
Market median
-751999% vs market
20122024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20122024
Return on equity
-0.8%
This company
18.4%
Market median
-104% vs market
20122024
Net profit margin
-118800.0%
This company
8.1%
Market median
-1466767% vs market
20122024
Asset turnover
-0.01×
This company
1.12×
Market median
-101% vs market
20122024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via CVR / Virk · Period 2018-10-01 – 2019-09-30
- Annual report 2018Filed via CVR / Virk · Period 2017-10-01 – 2018-09-30
- Annual report 2017Filed via CVR / Virk · Period 2016-10-01 – 2017-09-30
- Annual report 2016Filed via CVR / Virk · Period 2015-10-01 – 2016-09-30
- Annual report 2015Filed via CVR / Virk · Period 2014-10-01 – 2015-09-30
- Annual report 2014Filed via CVR / Virk · Period 2013-10-01 – 2014-09-30
- Annual report 2013Filed via CVR / Virk · Period 2012-10-01 – 2013-09-30
- Annual report 2012Filed via CVR / Virk · Period 2011-10-01 – 2012-09-30
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KHARMS 22 ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|